Marco Gattorno Selected Research

autosomal dominant familial Periodic fever

1/2017	Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
6/2013	Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
5/2013	Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.
1/2013	Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
11/2012	Biologic drugs in autoinflammatory syndromes.
7/2011	Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
3/2006	Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Gattorno Research Topics

Disease

33	Inflammation (Inflammations) 10/2022 - 05/2008
20	Fever (Fevers) 10/2022 - 03/2005
17	Cryopyrin-Associated Periodic Syndromes 01/2022 - 09/2007
15	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 10/2004
14	Mevalonate Kinase Deficiency 01/2022 - 05/2008
12	Pericarditis 01/2022 - 01/2009
12	Arthritis (Polyarthritis) 08/2019 - 04/2002
9	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 05/2008
7	Necrosis 01/2022 - 05/2013
7	autosomal dominant familial Periodic fever 01/2017 - 03/2006
6	COVID-19 10/2022 - 07/2020
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 12/2014
6	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2021 - 05/2013
5	Exanthema (Rash) 10/2022 - 07/2006
5	Hypoxia (Hypoxemia) 01/2017 - 06/2008
4	Macrophage Activation Syndrome 10/2022 - 01/2020
4	Lymphadenopathy 01/2022 - 05/2008
4	Bites and Stings (Sting) 01/2022 - 01/2017
3	Abdominal Pain (Pain, Abdominal) 10/2022 - 08/2019
3	Lupus Nephritis 10/2021 - 03/2002
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2021 - 09/2010
3	Agammaglobulinemia (Hypogammaglobulinemia) 10/2021 - 01/2017
3	Stroke (Strokes) 01/2021 - 07/2006
3	Lymphadenitis (Adenitis) 04/2018 - 05/2013
3	Hereditary Autoinflammatory Diseases 01/2018 - 11/2009
3	Acne Vulgaris 01/2016 - 05/2013
2	Arthralgia (Joint Pain) 10/2022 - 01/2022
2	Lung Diseases (Lung Disease) 10/2022 - 07/2020
2	Proteostasis Deficiencies 01/2022 - 01/2020
2	Tonsillitis 01/2022 - 01/2017
2	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 01/2022 - 01/2022
2	Lymphopenia (Lymphocytopenia) 10/2021 - 11/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021 - 01/2017
2	Pneumonia (Pneumonitis) 10/2021 - 01/2021
2	Schmid-Fraccaro syndrome 09/2021 - 09/2016
2	hyperzincemia and hypercalprotectinemia 01/2021 - 11/2015
2	Cytokine Release Syndrome 01/2021 - 01/2020
2	Infectious Mononucleosis (Glandular Fever) 12/2020 - 01/2017
2	Dermatomyositis (Dermatopolymyositis) 01/2020 - 07/2005
2	Aphthous Stomatitis (Aphthous Ulcer) 08/2019 - 04/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 09/2012
2	Infections 01/2018 - 03/2011
2	Skin Manifestations 10/2017 - 09/2016
2	Sensorineural Hearing Loss 06/2017 - 09/2016
2	Pain (Aches) 05/2017 - 01/2010
2	Pyoderma Gangrenosum 01/2016 - 12/2014
2	Chronic Disease (Chronic Diseases) 04/2013 - 11/2012
2	Serositis 01/2012 - 05/2008
2	Proteinuria 09/2010 - 02/2002
2	Synovitis 01/2010 - 08/2002

Drug/Important Bio-Agent (IBA)

21	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2022 - 09/2007
16	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2002
16	Interleukin-1 (Interleukin 1)IBA 01/2022 - 09/2007
14	Colchicine FDA LinkGeneric 01/2022 - 06/2014
11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2014
10	CytokinesIBA 10/2022 - 10/2004
10	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 09/2007
9	canakinumab FDA Link 01/2022 - 02/2013
8	Adenosine DeaminaseIBA 11/2022 - 09/2016
8	AutoantibodiesIBA 01/2021 - 09/2010
7	C-Reactive ProteinIBA 01/2022 - 11/2016
6	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2022 - 04/2011
6	InflammasomesIBA 10/2022 - 01/2011
6	InterleukinsIBA 01/2019 - 12/2011
5	InterferonsIBA 01/2022 - 09/2010
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2006
4	NLR ProteinsIBA 10/2022 - 05/2010
4	SteroidsIBA 10/2021 - 11/2012
4	Pharmaceutical PreparationsIBA 03/2021 - 03/2002
3	AntibodiesIBA 10/2021 - 07/2006
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 09/2010
3	Intravenous Immunoglobulins (IVIG)FDA Link 10/2021 - 01/2021
3	Proline (L-Proline)FDA Link 01/2021 - 11/2015
3	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021 - 11/2015
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019 - 05/2008
3	Interleukin-1beta (Interleukin 1 beta)IBA 11/2009 - 09/2007
2	Interferon Type IIBA 11/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2014
2	rilonacept FDA Link 01/2022 - 03/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 12/2021 - 07/2006
2	Transaminases (Aminotransferases)IBA 10/2021 - 11/2016
2	Adalimumab (Humira)FDA Link 01/2021 - 09/2016
2	Methylprednisolone FDA LinkGeneric 01/2021 - 01/2021
2	LigandsIBA 12/2020 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 01/2020 - 05/2008
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2019 - 06/2017
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018 - 11/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 09/2012
2	ChemokinesIBA 01/2017 - 06/2008
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 09/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015 - 06/2013
2	EnzymesIBA 11/2012 - 03/2005
2	mevalonate kinaseIBA 11/2012 - 03/2005
2	Chemokine ReceptorsIBA 07/2005 - 01/2005
2	Peptide Hydrolases (Proteases)FDA Link 08/2002 - 04/2002
2	Matrix Metalloproteinases (MMPs)IBA 08/2002 - 04/2002

Therapy/Procedure

22	Therapeutics 10/2022 - 03/2002
3	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2015
2	Stem Cell Transplantation 10/2021 - 07/2021